Active
    Mainboard

    Symbiotec Pharmalab Ltd

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Symbiotec Pharmalab Ltd IPO opened on 24 Aug 2026 and closed on 27 Aug 2026, with a price band of ₹938–₹988 per share. The IPO had a lot size of 15 shares, requiring a minimum investment of ₹14,820 per lot at the upper price band. The issue size was ₹1757 crore, and the shares get listed on 01 Sep 2026.

    Symbiotec Pharmalab Ltd IPO Details

    Listing Date

    01 Sep 2026

    Bid Price

    ₹938 - ₹988

    Lot Size

    15 Shares

    Minimum Investment

    ₹14,820 / Lot

    Issue Size

    ₹1757 Cr

    Employee Discount

    ₹90 per share

    Key Dates to Track

        Here are the important dates you need to know in order to participate in this IPO

    tick

    Offer Start Date

    24th Aug

    tick

    Offer End Date

    27th Aug

    tick

    Allotment Date

    28th Aug

    tick

    Refund Initiation

    28th Aug

    tick

    Demat Transfer

    31st Aug

    tick

    Listing Date

    1st Sep

    Symbiotec Pharmalab Ltd Shareholding Pattern

      Pre-Issue Post-Issue
    Promoter Group 36.39% 33.27%
    Public Group 63.61% 66.73%

    Symbiotec Pharmalab Ltd IPO Reservation

    QIB Shares Offered 35,50,608 (19.96%)
    NII (HNI) Shares Offered 26,62,955 (14.97%)
    Retail Shares Offered 62,13,562 (34.93%)
    Anchor Investor Shares Offered 53,25,910 (29.94%)
    Total Shares Offered 1,77,86,442
    Total Shares With Anchor Investor 1,77,86,442

    Symbiotec Pharmalab Ltd IPO Lot Size

    Application Lots Shares Amount
    Retail (Min) 1 15 ₹14,820
    Retail (Max) 13 195 ₹1,92,660
    S HNI (Min) 14 210 ₹2,07,480
    S HNI (Max) 67 1,005 ₹9,92,940
    B HNI (MIN) 68 1,020 ₹10,07,760

    Symbiotec Pharmalab Ltd IPO Anchor Portion Size

    Bid Date August 21, 2026
    Shares Offered 53,25,909
    Anchor Investment Details 526

    Symbiotec Pharmalab Ltd IPO registrar

    MUFG Intime India Pvt Ltd
    Phone Number +91 810 811 4949
    Email Id symbiotecpharmalab.ipo@in.mpms.mufg.com
    Website https://in.mpms.mufg.com

    Symbiotec Pharmalab Ltd IPO Lead Manager

    1. JM Financial Limited

    2. Avendus Capital Private Limited

    3. Motilal Oswal Investment Advisors Limited

    4. Nomura Financial Advisory & Securities (I) Pvt Ltd

    Symbiotec Pharmalab Ltd Financial Information

    March 31, 2026 March 31, 2025 March 31, 2024
    Net Worth ₹1,149.73 Cr ₹814.89 Cr ₹715.05 Cr
    Reserves and Surplus ₹1,137.18 Cr ₹803.96 Cr ₹704.11 Cr
    Total Borrowing ₹387.91 Cr ₹540.92 Cr ₹247.21 Cr

    Symbiotec Pharmalab Ltd IPO Subscription LIVE Status

    Category No. of shares offered No. of shares bid Subscription (Times)
    Qualified Institutional Buyers (QIBs) 37,39,872 64,33,59,195 172.0271
    Non Institutional Investors (NIIs) 28,04,904 20,65,35,120 73.6336
    Retail Individual Investors (RIIs) 65,44,776 8,48,10,330 12.9585
    Total 1,31,24,929 93,52,49,700 71.26

    Strength of Symbiotec Pharmalab Ltd

    • Global leadership in corticosteroid and steroidal hormone APIs.
    • Long-standing relationships with domestic and global customer base.
    • Fully-invested, multi-scale, vertically integrated manufacturing platform with sustainable practices and clean regulatory track record.
    • Continuous investment in R&D, with leading technological capabilities among Indian peers.
    • Ability to leverage science and existing competencies to increase total addressable market and deepen intellectual property-driven offerings.

    Risks Involved

    • The company derives almost all of its revenue from the sale of APIs, which collectively constituted 96.07%, 99.10% and 100.00% of the company's revenue from operations in Fiscals 2026, 2025 and 2024, respectively. Further, its top five APIs constituted 62.27%, 63.16% and 60.37% of the company's revenue from operations in Fiscals 2026, 2025 and 2024, respectively. Any reduction in demand for APIs, and its top products in particular, or disruption in production, could have an adverse effect on the company's business, results of operations, financial condition and cash flows.
    • The company's manufacturing facilities is subject to periodic inspections and audits by regulatory authorities and its customers. Any manufacturing or quality control failures may subject it to regulatory action, damage the company's reputation and have an adverse effect on its business, results of operations, financial condition and cash flows.
    • The company exports its products to various countries and the company's revenue from external customers outside India as per Ind AS 108 - "Operating Segments" represented 67.04%, 55.19% and 59.97% of its revenue from operations in Fiscals 2026, 2025 and 2024, respectively. The company's inability to handle risks associated with its export sales could adversely affect the company's sales to customers in foreign countries, its results of operations, financial condition and cash flows.
    • In Fiscals 2026, 2025 and 2024, revenue from the United States represented 13.12%, 4.02% and 8.97% of the company's revenue from operations. The imposition of tariffs or other anti-outsourcing legislation by the United States could adversely affect its results of operations, financial condition and cash flows.
    • The company derives a substantial portion of its revenue from certain key customers. Revenue generated from the company's top ten customers accounted for 57.59%, 55.90% and 61.65% of its revenue from sale of product in Fiscals 2026, 2025 and 2024, respectively. Loss of the company's relationship with any of these customers or delays or reductions in their orders could have an adverse effect on its business, results of operations, financial condition and cash flows.
    • The company's manufacturing facilities and dedicated R&D centres are located in the state of Madhya Pradesh in India. Any adverse developments affecting Madhya Pradesh or its surrounding regions could adversely affect its business, results of operations, financial condition and cash flows. A slowdown, interruption or shutdown in the company's manufacturing operations could have an adverse effect on its business, results of operations, financial condition and cash flows.
    • The company depends on certain suppliers for raw materials for its operations. Purchases from the company's top ten suppliers accounted for 25.50%, 18.41% and 50.33% of its total expenses in Fiscals 2026, 2025 and 2024, respectively. Any loss of such suppliers or non-performance of their obligations could adversely affect the company's business, results of operations, financial condition and cash flows.
    • The company operates in a highly competitive market. Its faces competition both within the company's API manufacturing business and in its role as a CDMO, which the company has recently commenced. An inability to compete effectively may adversely affect its business, results of operations, financial condition and cash flows.
    • The company procures a portion of its raw material requirements from different countries, including China and the United States. Any adverse developments in these countries, or the laws governing the company's imports from these countries, could disrupt its raw material supply and adversely affect the company's results of operations, financial condition and cash flows.
    • The company's success depends on its ability to develop and commercialise new products in a timely manner. If the company's research and development efforts does not succeed, or the products its commercialise does not perform as expected, the introduction of new products may be hindered, which could adversely affect the company's business, results of operations, financial condition and cash flows.

    Invest in IPOs with ease

    Sign-in to invest with your demat account, or set up a new demat account for free

    Explore Other IPOs

    • Current IPOs
    • Upcoming IPOs
    • Closed IPOs
    • IPO Performance
    • All
    • MainBoard
    • SME
    CORE4 ENGINEERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    23rd Oct 2026 - 10th Oct 2026
    Price Range
    ₹88.0 - 93.0
    IPO Size
    ₹54,82,00,000
    • All
    • MainBoard
    • SME
    Bidding Period
    26th Oct 2026 - 10th Oct 2026
    Price Range
    ₹1585.0 - 1665.0
    IPO Size
    ₹12,00,00,00,000
    BLS Polymers Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹142.0 - 150.0
    IPO Size
    ₹2,55,00,00,128
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹313.0 - 330.0
    IPO Size
    ₹6,67,53,00,352
    Wiscon Industries Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹194.0 - 204.0
    IPO Size
    ₹1,10,00,00,000
    Carver Roboweld Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Oct 2026 - 10th Oct 2026
    Price Range
    ₹76.0 - 80.0
    IPO Size
    ₹0
    Bidding Period
    29th Oct 2026 - 11th Nov 2026
    Price Range
    ₹78.0 - 82.0
    IPO Size
    ₹1,83,05,99,936
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanced SysTek Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanta Enterprises Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Agilus Diagnostics Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AGS Health Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Airox Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AITMC Ventures Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ajay Poly Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Allchem Lifescience Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    NO ACTIVE IPO HERE
    • All
    • MainBoard
    • SME
    JIO PLATFORMS LIMITED IPO
    icon
    Closing Today
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹1065.0 - 1119.0
    IPO Size
    ₹3,02,13,00,03,968
    PARAS HEALTHCARE LIMITED IPO
    icon
    Closing Today
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹660.0 - 693.0
    IPO Size
    ₹14,49,99,99,744
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹327.0 - 344.0
    IPO Size
    ₹4,75,48,00,128
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹558.0 - 586.0
    IPO Size
    ₹25,33,80,99,712
    SHELLZ INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹170.0 - 179.0
    IPO Size
    ₹59,97,00,032
    TONBO IMAGING INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹665.0 - 700.0
    IPO Size
    ₹8,52,17,99,680
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹143.0 - 151.0
    IPO Size
    ₹50,12,33,00,864
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹275.0 - 289.0
    IPO Size
    ₹7,02,00,00,256
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹105.0 - 112.0
    IPO Size
    ₹1,16,04,99,968
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹258.0 - 271.0
    IPO Size
    ₹7,12,12,99,968
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹51.0 - 54.0
    IPO Size
    ₹42,10,00,000
    Bidding Period
    5th Oct 2026 - 10th Oct 2026
    Price Range
    ₹77.0 - 82.0
    IPO Size
    ₹34,99,00,032
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹119.0 - 127.0
    IPO Size
    ₹81,79,00,032
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹186.0 - 196.0
    IPO Size
    ₹1,21,68,99,968
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹37,86,00,000
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹208.0 - 220.0
    IPO Size
    ₹1,78,00,00,000
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Sep 2026 - 10th Oct 2026
    Price Range
    ₹50.0 - 53.0
    IPO Size
    ₹31,80,00,000
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹67.0 - 67.0
    IPO Size
    ₹23,45,00,000
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹55.0 - 55.0
    IPO Size
    ₹21,78,00,000
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹112.0 - 118.0
    IPO Size
    ₹38,12,00,000
    • All
    • MainBoard
    • SME
    Issue Prize
    1785.00
    Listing Day Close
    1818.00(1.85%)
    LAPL AUTOMOTIVE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    94.00
    Listing Day Close
    128.29(36.17%)
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    289.00
    Listing Day Close
    289.75(0.35%)
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    271.00
    Listing Day Close
    307.20(13.28%)
    Issue Prize
    112.00
    Listing Day Close
    113.70(1.79%)
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    54.00
    Listing Day Close
    53.05(-1.85%)
    Issue Prize
    82.00
    Listing Day Close
    76.00(-7.32%)
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    127.00
    Listing Day Close
    109.25(-14.17%)
    Issue Prize
    196.00
    Listing Day Close
    232.05(18.37%)
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    70.00
    Listing Day Close
    58.80(-15.71%)
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    220.00
    Listing Day Close
    204.25(-7.27%)
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    53.00
    Listing Day Close
    57.00(7.55%)
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    67.00
    Listing Day Close
    73.01(8.96%)
    Issue Prize
    55.00
    Listing Day Close
    99.18(80.00%)
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    118.00
    Listing Day Close
    105.45(-11.02%)
    Issue Prize
    85.00
    Listing Day Close
    119.70(41.18%)
    Issue Prize
    75.00
    Listing Day Close
    84.15(12.00%)
    OMARA VENTURES INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    311.00
    Listing Day Close
    319.05(2.57%)
    Issue Prize
    72.00
    Listing Day Close
    68.75(-4.17%)
    GREEN ASIA IMPEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    89.00
    Listing Day Close
    84.55(-4.49%)

    Frequently Asked Questions

    What is Symbiotec Pharmalab Ltd IPO?

    Symbiotec Pharmalab Ltd IPO is a Mainboard IPO of 1,77,86,442 equity shares of a face value of ₹2 aggregating up to ₹1757 Crores. The issue is priced at ₹938 to ₹988 per share. The minimum order quantity is 15 Shares. The IPO opens on August 24, 2026, and closes on August 27, 2026. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

    When Symbiotec Pharmalab Ltd IPO will open?

    The Symbiotec Pharmalab Ltd IPO opens on August 24, 2026 and closes on August 27, 2026.

    What is the lot size of Symbiotec Pharmalab Ltd?

    Symbiotec Pharmalab Ltd lot size is 15 shares, and the minimum amount required is ₹14,820.

    How to apply for Symbiotec Pharmalab Ltd IPO?

    You can apply in Symbiotec Pharmalab Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

    • Login to Bajaj Broking account App/Website & click on IPO
    • Enter the number of lots and price at which you wish to apply.
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
    • You will receive a mandate notification to block funds in your UPI app.
    • Approve the mandate request on your UPI and funds will be blocked.

    When is Symbiotec Pharmalab Ltd IPO allotment?

    The finalization of Basis of Allotment for Symbiotec Pharmalab Ltd IPO will be done on August 28, 2026, and the allotted shares will be credited to your demat account by August 31, 2026.

    When is Symbiotec Pharmalab Ltd IPO listing date?

    The Symbiotec Pharmalab Ltd listing date is September 01, 2026.

    Who is the registrar of Symbiotec Pharmalab Ltd IPO?

    The registrar of Symbiotec Pharmalab Ltd IPO is MUFG Intime India Pvt Ltd

    Which company is the book-running lead manager of the IPO?

    JM Financial Limited,Avendus Capital Private Limited,Motilal Oswal Investment Advisors Limited,Nomura Financial Advisory & Securities (I) Pvt Ltd will be the book-running lead manager of this IPO.

    What is the fresh issue of Symbiotec Pharmalab Ltd IPO?

    The fresh issue size is ₹150 Crores equity shares.

    What minimum lot size can retail subscribers subscribe to Symbiotec Pharmalab Ltd?

    Retail investors can subscribe to a minimum of one lot, 15 shares and ₹14,820 amount.

    How can I approve the UPI mandate request for Symbiotec Pharmalab Ltd IPO?

    To apply for Symbiotec Pharmalab Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

    What is the price range of Symbiotec Pharmalab Ltd?

    The price of each Symbiotec Pharmalab Ltd share will be ranging in between ₹938 to ₹988 per share.

    What is the cut-off time for the UPI mandate for Symbiotec Pharmalab Ltd IPO?

    The cut-off time for the UPI mandate confirmation is 5:00 PM, August 27, 2026.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |